The Integrin Inhibitor Cilengitide Affects Meningioma Cell Motility and Invasion

Abstract

These data show that a monotherapy with cilengitide is not likely to achieve major responses in rapidly growing malignant meningiomas, although brain invasion may be reduced because of the strong antimigratory properties of the drug. The combination with radiotherapy warrants further attention.